8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 2, 2026·SEC
Material company update
Feb 5, 2026·SEC
Illumina, Inc.(ILMN)Earnings, Financials & Key Ratios
ILMN•NASDAQ
29.7× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutIllumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.Show more
- Revenue$4.34B-0.8%
- EBITDA$1.13B+336.7%
- Net Income$850M+169.5%
- EPS (Diluted)5.45+170.9%
- Gross Margin66.69%+1.9%
- EBITDA Margin26.14%+338.6%
- Operating Margin19.92%+204.5%
- Net Margin19.59%+170.0%
- ROE33.36%+210.7%
ILMN Key Insights
Illumina, Inc. (ILMN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong Piotroski F-Score: 8/9
- ✓FCF machine: 21.5% free cash flow margin
- ✓Momentum leader: RS Rating 86 (top 14%)
- ✓High quality earnings: Operating CF exceeds net income
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ILMN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ILMN Price & Volume
Illumina, Inc. (ILMN) stock price & volume — 10-year historical chart
Loading chart...
ILMN Growth Metrics
Illumina, Inc. (ILMN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years6.93%
5 Years6.02%
3 Years-1.82%
TTM1.25%
Profit CAGR
10 Years6.3%
5 Years5.32%
3 Years-
TTM188.39%
EPS CAGR
10 Years5.8%
5 Years4.23%
3 Years-
TTM190.33%
Return on Capital
10 Years3.31%
5 Years-8.68%
3 Years-2.26%
Last Year17.61%
ILMN Recent Earnings
Illumina, Inc. (ILMN) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$1.15+9.5%
$1.05
Rev
$1.1B+1.7%
$1.1B
Q1 2026
Feb 5, 2026Metric
Actual
Est
EPS
$1.35+8.9%
$1.24
Rev
$1.2B+3.6%
$1.1B
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$1.34+14.5%
$1.17
Rev
$1.1B+1.6%
$1.1B
Q3 2025
Jul 31, 2025Metric
Actual
Est
EPS
$1.19+16.7%
$1.02
Rev
$1.1B-0.6%
$1.1B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $1.15vs $1.05+9.5% | $1.1Bvs $1.1B+1.7% |
| Q1 2026 | Feb 5, 2026 | $1.35vs $1.24+8.9% | $1.2Bvs $1.1B+3.6% |
| Q4 2025 | Oct 30, 2025 | $1.34vs $1.17+14.5% | $1.1Bvs $1.1B+1.6% |
| Q3 2025 | Jul 31, 2025 | $1.19vs $1.02+16.7% | $1.1Bvs $1.1B-0.6% |
Based on last 12 quarters of dataView full earnings history →
ILMN Peer Comparison
Illumina, Inc. (ILMN) competitors in Life Science Instruments and Sequencing Tools — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PACB | 434.84M | 1.40 | -0.77 | 3.89% | -80.34% | -488.45% | 141.98 | |
 BRKR | 8.71B | 57.23 | -381.53 | 2.08% | -0.34% | -0.5% | 0.81 | |
 TMO | 172.66B | 464.61 | 26.19 | 3.91% | 15.18% | 13.23% | 0.76 | |
 DHR | 125.4B | 177.17 | 35.15 | 2.9% | 14.89% | 7.06% | 0.35 | |
 A | 35.89B | 127.06 | 27.80 | 6.73% | 19.55% | 20.84% | 0.50 | |
 BIO | 7.63B | 282.44 | 10.13 | 0.65% | 6.52% | 2.4% | 0.21 | |
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 |
Compare ILMN vs Peers
Illumina, Inc. (ILMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ILMN Income Statement
Illumina, Inc. (ILMN) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 2.75B | 3.33B | 3.54B | 3.24B | 4.53B | 4.58B | 4.5B | 4.37B | 4.34B | 4.39B |
Revenue Growth % | 14.74% | 21.11% | 6.3% | -8.58% | 39.73% | 1.28% | -1.75% | -2.93% | -0.78% | 1.25% |
Cost of Goods Sold | 926M | 1.03B | 1.08B | 1.04B | 1.37B | 1.61B | 1.76B | 1.51B | 1.45B | 1.44B |
COGS % of Revenue | 33.65% | 30.99% | 30.37% | 31.99% | 30.31% | 35.17% | 39.08% | 34.56% | 33.31% | - |
Gross Profit | 1.83B▲ 0% | 2.3B▲ 26.0% | 2.47B▲ 7.3% | 2.2B▼ 10.7% | 3.15B▲ 43.2% | 2.97B▼ 5.8% | 2.74B▼ 7.7% | 2.86B▲ 4.3% | 2.89B▲ 1.1% | 2.95B▲ 0% |
Gross Margin % | 66.35% | 69.01% | 69.63% | 68.01% | 69.69% | 64.83% | 60.92% | 65.44% | 66.69% | 67.14% |
Gross Profit Growth % | 9.6% | 25.96% | 7.26% | -10.7% | 43.17% | -5.77% | -7.67% | 4.26% | 1.12% | - |
Operating Expenses | 1.22B | 1.42B | 1.48B | 1.62B | 3.28B | 7.15B | 3.81B | 3.69B | 2.03B | 2.03B |
OpEx % of Revenue | 44.33% | 42.51% | 41.83% | 50.11% | 72.4% | 156% | 84.66% | 84.49% | 46.77% | - |
Selling, General & Admin | 674M | 794M | 835M | 941M | 2.09B | 1.3B | 1.61B | 1.09B | 1.08B | 1.08B |
SG&A % of Revenue | 24.49% | 23.82% | 23.57% | 29.05% | 46.22% | 28.29% | 35.79% | 24.98% | 24.85% | - |
Research & Development | 546M | 623M | 647M | 682M | 1.19B | 1.32B | 1.35B | 1.17B | 951M | 949M |
R&D % of Revenue | 19.84% | 18.69% | 18.26% | 21.06% | 26.18% | 28.82% | 30.06% | 26.74% | 21.92% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 4.53B | 847M | 1.43B | 0 | 0 |
Operating Income | 606M▲ 0% | 883M▲ 45.7% | 985M▲ 11.6% | 580M▼ 41.1% | -123M▼ 121.2% | -4.18B▼ 3297.6% | -1.07B▲ 74.4% | -833M▲ 22.1% | 864M▲ 203.7% | 919M▲ 0% |
Operating Margin % | 22.02% | 26.49% | 27.8% | 17.91% | -2.72% | -91.16% | -23.73% | -19.05% | 19.92% | 20.93% |
Operating Income Growth % | 3.24% | 45.71% | 11.55% | -41.12% | -121.21% | -3297.56% | 74.42% | 22.08% | 203.72% | - |
EBITDA | 762M | 1.06B | 1.17B | 767M | 128M | -3.79B | -637M | -479M | 1.13B | 1.12B |
EBITDA Margin % | 27.69% | 31.86% | 33.11% | 23.68% | 2.83% | -82.57% | -14.14% | -10.96% | 26.14% | 25.53% |
EBITDA Growth % | 4.67% | 39.37% | 10.45% | -34.61% | -83.31% | -3057.03% | 83.17% | 24.8% | 336.74% | 674.87% |
D&A (Non-Cash Add-back) | 156M | 179M | 188M | 187M | 251M | 394M | 432M | 354M | 270M | 202M |
EBIT | 1.08B | 951M | 1.17B | 905M | 945M | -4.31B | -1.04B | -1.08B | 864M | 919M |
Net Interest Income | -18M | -13M | 23M | -8M | -61M | -15M | -19M | -54M | -61M | -47M |
Interest Income | 19M | 44M | 75M | 41M | 0 | 11M | 58M | 46M | 40M | 29M |
Interest Expense | 37M | 57M | 52M | 49M | 61M | 26M | 77M | 100M | 101M | 76M |
Other Income/Expense | 437M | 11M | 133M | 276M | 1.01B | -157M | -48M | -346M | 222M | 142M |
Pretax Income | 1.04B▲ 0% | 894M▼ 14.3% | 1.12B▲ 25.1% | 856M▼ 23.4% | 884M▲ 3.3% | -4.34B▼ 590.5% | -1.12B▲ 74.2% | -1.18B▼ 5.6% | 1.09B▲ 192.1% | 1.06B▲ 0% |
Pretax Margin % | 37.9% | 26.82% | 31.56% | 26.43% | 19.53% | -94.59% | -24.8% | -26.97% | 25.03% | 24.16% |
Income Tax | 365M | 112M | 128M | 200M | 122M | 68M | 44M | 44M | 236M | 208M |
Effective Tax Rate % | 35% | 12.53% | 11.45% | 23.36% | 13.8% | -1.57% | -3.94% | -3.73% | 21.73% | 19.6% |
Net Income | 726M▲ 0% | 826M▲ 13.8% | 1B▲ 21.3% | 656M▼ 34.5% | 762M▲ 16.2% | -4.4B▼ 678.0% | -1.16B▲ 73.6% | -1.22B▼ 5.3% | 850M▲ 169.5% | 853M▲ 0% |
Net Margin % | 26.38% | 24.78% | 28.28% | 20.25% | 16.84% | -96.07% | -25.78% | -27.97% | 19.59% | 19.43% |
Net Income Growth % | 56.92% | 13.77% | 21.31% | -34.53% | 16.16% | -677.95% | 73.64% | -5.34% | 169.5% | 188.39% |
Net Income (Continuing) | 678M | 782M | 990M | 656M | 762M | -4.4B | -1.16B | -1.22B | 850M | 853M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 220M | 87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 4.91▲ 0% | 5.54▲ 12.8% | 6.72▲ 21.3% | 4.43▼ 34.1% | 5.05▲ 14.0% | -28.05▼ 655.4% | -7.35▲ 73.8% | -7.69▼ 4.6% | 5.45▲ 170.9% | 5.54▲ 0% |
EPS Growth % | 56.87% | 12.83% | 21.3% | -34.08% | 14% | -655.45% | 73.8% | -4.63% | 170.87% | 190.33% |
EPS (Basic) | 4.97 | 5.62 | 6.82 | 4.46 | 5.08 | -28.05 | -7.35 | -7.69 | 5.48 | - |
Diluted Shares Outstanding | 148M | 149M | 149M | 148M | 151M | 157M | 158M | 159M | 156M | 154M |
Basic Shares Outstanding | 146M | 147M | 147M | 147M | 150M | 157M | 158M | 159M | 155M | 153M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ILMN Balance Sheet
Illumina, Inc. (ILMN) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 2.98B | 4.49B | 4.45B | 4.48B | 2.71B | 3.56B | 2.61B | 2.75B | 3.29B | 2.74B |
Cash & Short-Term Investments | 2.15B | 3.51B | 3.41B | 3.47B | 1.34B | 2.04B | 1.05B | 1.22B | 1.63B | 1.16B |
Cash Only | 1.23B | 1.14B | 2.04B | 1.81B | 1.23B | 2.01B | 1.05B | 1.13B | 1.42B | 1.09B |
Short-Term Investments | 920M | 2.37B | 1.37B | 1.66B | 107M | 26M | 6M | 93M | 215M | 66M |
Accounts Receivable | 411M | 514M | 573M | 487M | 664M | 688M | 752M | 751M | 854M | 738M |
Days Sales Outstanding | 54.51 | 56.29 | 59.03 | 54.88 | 53.55 | 54.78 | 60.94 | 62.7 | 71.86 | 63.57 |
Inventory | 333M | 386M | 359M | 372M | 431M | 568M | 587M | 547M | 564M | 611M |
Days Inventory Outstanding | 131.26 | 136.39 | 121.78 | 131.06 | 114.66 | 128.61 | 121.74 | 132.13 | 142.46 | 147.97 |
Other Current Assets | 91M | 78M | 105M | 152M | 0 | 268M | 216M | 228M | 238M | 234M |
Total Non-Current Assets | 2.28B | 2.47B | 2.87B | 3.1B | 12.5B | 8.69B | 7.5B | 3.56B | 3.35B | 3.82B |
Property, Plant & Equipment | 931M | 1.07B | 1.44B | 1.45B | 1.7B | 1.74B | 1.55B | 1.23B | 1.13B | 1.13B |
Fixed Asset Turnover | 2.96x | 3.10x | 2.45x | 2.23x | 2.67x | 2.63x | 2.90x | 3.54x | 3.84x | 3.86x |
Goodwill | 771M | 831M | 824M | 897M | 7.11B | 3.24B | 2.54B | 1.11B | 1.11B | 1.28B |
Intangible Assets | 175M | 185M | 145M | 142M | 3.25B | 3.29B | 2.99B | 295M | 210M | 430M |
Long-Term Investments | 266M | 260M | 283M | 418M | 213M | 211M | 196M | 227M | 0 | 598M |
Other Non-Current Assets | 46M | 48M | 105M | 171M | 232M | 212M | 217M | 121M | 449M | 523M |
Total Assets | 5.26B▲ 0% | 6.96B▲ 32.4% | 7.32B▲ 5.1% | 7.58B▲ 3.7% | 15.22B▲ 100.6% | 12.25B▼ 19.5% | 10.11B▼ 17.5% | 6.3B▼ 37.7% | 6.64B▲ 5.4% | 6.56B▲ 0% |
Asset Turnover | 0.52x | 0.48x | 0.48x | 0.43x | 0.30x | 0.37x | 0.45x | 0.69x | 0.65x | 0.69x |
Asset Growth % | 22.81% | 32.38% | 5.13% | 3.68% | 100.62% | -19.48% | -17.47% | -37.66% | 5.41% | 14.32% |
Total Current Liabilities | 746M | 1.8B | 665M | 1.24B | 1.09B | 2.77B | 1.57B | 1.55B | 1.58B | 1.57B |
Accounts Payable | 160M | 184M | 149M | 192M | 332M | 293M | 245M | 221M | 240M | 218M |
Days Payables Outstanding | 63.07 | 65.01 | 50.54 | 67.64 | 88.32 | 66.34 | 50.81 | 53.39 | 60.62 | 55.4 |
Short-Term Debt | 10M | 1.11B | 45M | 562M | 0 | 1.25B | 0 | 578M | 499M | 499M |
Deferred Revenue (Current) | 130M | 175M | 167M | 186M | 234M | 245M | 252M | 260M | 270M | 751M |
Other Current Liabilities | 219M | 63M | 64M | 83M | 241M | 188M | 223M | 70M | 249M | 849M |
Current Ratio | 3.99x | 2.49x | 6.69x | 3.60x | 2.48x | 1.28x | 1.66x | 1.78x | 2.08x | 1.75x |
Quick Ratio | 3.55x | 2.27x | 6.15x | 3.30x | 2.09x | 1.08x | 1.29x | 1.42x | 1.72x | 1.36x |
Cash Conversion Cycle | 122.7 | 127.66 | 130.27 | 118.3 | 79.89 | 117.05 | 131.87 | 141.45 | 153.7 | 156.15 |
Total Non-Current Liabilities | 1.67B | 1.31B | 2.04B | 1.65B | 3.38B | 2.88B | 2.8B | 2.38B | 2.34B | 1.97B |
Long-Term Debt | 1.18B | 890M | 1.14B | 673M | 1.7B | 1.49B | 1.49B | 1.49B | 1.49B | 1.97B |
Capital Lease Obligations | 0 | 269M | 695M | 671M | 774M | 744M | 687M | 554M | 486M | 1.52B |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 360M | 359M | 160M | 259M | 915M | 649M | 620M | 272M | 360M | 0 |
Total Liabilities | 2.29B | 3.05B | 2.7B | 2.89B | 4.48B | 5.65B | 4.37B | 3.93B | 3.92B | 3.53B |
Total Debt | 1.19B | 2B | 1.88B | 1.91B | 2.54B | 3.56B | 2.26B | 2.62B | 2.55B | 2.46B |
Net Debt | -33M | 853M | -161M | 96M | 1.31B | 1.54B | 1.21B | 1.5B | 1.14B | 1.38B |
Debt / Equity | 0.39x | 0.51x | 0.41x | 0.41x | 0.24x | 0.54x | 0.39x | 1.10x | 0.94x | 0.81x |
Debt / EBITDA | 1.56x | 1.88x | 1.60x | 2.49x | 19.84x | - | - | - | 2.25x | 2.20x |
Net Debt / EBITDA | -0.04x | 0.80x | -0.14x | 0.13x | 10.22x | - | - | - | 1.00x | 1.23x |
Interest Coverage | 29.19x | 16.68x | 22.50x | 18.47x | 15.49x | -165.77x | -13.51x | -10.79x | 8.55x | 12.09x |
Total Equity | 3.06B▲ 0% | 3.93B▲ 28.3% | 4.61B▲ 17.3% | 4.69B▲ 1.8% | 10.74B▲ 128.8% | 6.6B▼ 38.6% | 5.75B▼ 12.9% | 2.37B▼ 58.7% | 2.72B▲ 14.7% | 3.03B▲ 0% |
Equity Growth % | 30.76% | 28.33% | 17.32% | 1.76% | 128.8% | -38.56% | -12.94% | -58.69% | 14.75% | 111.91% |
Book Value per Share | 20.70 | 26.39 | 30.96 | 31.72 | 71.13 | 42.03 | 36.36 | 14.92 | 17.46 | 19.66 |
Total Shareholders' Equity | 2.84B | 3.85B | 4.61B | 4.69B | 10.74B | 6.6B | 5.75B | 2.37B | 2.72B | 3.03B |
Common Stock | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 0 |
Retained Earnings | 2.26B | 3.08B | 4.07B | 4.72B | 5.49B | 1.14B | -19M | -1.24B | -392M | 0 |
Treasury Stock | -2.34B | -2.62B | -3.02B | -3.85B | -3.7B | -3.75B | -3.79B | -3.93B | -4.7B | 0 |
Accumulated OCI | -1M | -1M | 5M | 2M | 17M | 3M | -1M | 22M | -10M | 0 |
Minority Interest | 220M | 87M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ILMN Cash Flow Statement
Illumina, Inc. (ILMN) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 875M | 1.14B | 1.05B | 1.08B | 545M | 392M | 478M | 837M | 1.08B | 1.13B |
Operating CF Margin % | 31.8% | 34.26% | 29.66% | 33.34% | 12.04% | 8.55% | 10.61% | 19.14% | 24.87% | - |
Operating CF Growth % | 27.32% | 30.51% | -7.97% | 2.76% | -49.54% | -28.07% | 21.94% | 75.1% | 28.91% | 190.98% |
Net Income | 678M | 782M | 990M | 656M | 762M | -4.4B | -1.16B | -1.22B | 850M | 853M |
Depreciation & Amortization | 156M | 179M | 188M | 187M | 251M | 394M | 432M | 354M | 270M | 65M |
Stock-Based Compensation | 164M | 193M | 194M | 194M | 754M | 366M | 380M | 370M | 0 | -3M |
Deferred Taxes | 81M | -18M | 11M | 117M | -76M | -23M | -33M | -112M | 119M | 62M |
Other Non-Cash Items | -399M | 24M | -138M | -147M | -994M | 3.85B | 950M | 1.93B | -7M | 587M |
Working Capital Changes | 195M | -18M | -194M | 73M | -152M | 204M | -90M | -483M | -153M | -70M |
Change in Receivables | -26M | -105M | -58M | 89M | -164M | -12M | -40M | -25M | -108M | -203M |
Change in Inventory | -33M | -53M | 25M | -12M | -58M | -135M | -20M | 19M | -17M | 1M |
Change in Payables | 10M | 45M | -35M | 40M | 60M | -38M | -44M | -4M | 2M | 43M |
Cash from Investing | -214M | -1.81B | 745M | -554M | -1.07B | -591M | -231M | -178M | -55M | -358M |
Capital Expenditures | -312M | -296M | -209M | -189M | -208M | -286M | -195M | -128M | -158M | -157M |
CapEx % of Revenue | 11.34% | 8.88% | 5.9% | 5.84% | 4.6% | 6.24% | 4.33% | 2.93% | 3.64% | 3.58% |
Acquisitions | -52M | -100M | -32M | -98M | -2.44B | -265M | -29M | 2M | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 96M | -1.42B | 0 | -132M | 0 | 0 | -1M | 0 | 0 | -371M |
Cash from Financing | -176M | 594M | -897M | -766M | -51M | 1B | -1.21B | -570M | -744M | -800M |
Debt Issued (Net) | -4M | 731M | -550M | 0 | 471M | 991M | -1.24B | 491M | -5M | -5M |
Equity Issued (Net) | -180M | -275M | -265M | -675M | 60M | 63M | 67M | -60M | -698M | -525M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -251M | -201M | -324M | -736M | 0 | 0 | 0 | -116M | -742M | -542M |
Other Financing | 8M | 138M | -82M | -91M | -582M | -54M | -42M | -1B | -41M | -270M |
Net Change in Cash | 490M▲ 0% | -81M▼ 116.5% | 898M▲ 1208.6% | -232M▼ 125.8% | -578M▼ 149.1% | 779M▲ 234.8% | -963M▼ 223.6% | 79M▲ 108.2% | 291M▲ 268.4% | -24M▲ 0% |
Free Cash Flow | 563M▲ 0% | 846M▲ 50.3% | 842M▼ 0.5% | 891M▲ 5.8% | 337M▼ 62.2% | 106M▼ 68.5% | 282M▲ 166.0% | 709M▲ 151.4% | 931M▲ 31.3% | 989M▲ 0% |
FCF Margin % | 20.46% | 25.38% | 23.77% | 27.51% | 7.45% | 2.31% | 6.26% | 16.22% | 21.46% | 22.52% |
FCF Growth % | 35.38% | 50.27% | -0.47% | 5.82% | -62.18% | -68.55% | 166.04% | 151.42% | 31.31% | 13.81% |
FCF per Share | 3.80 | 5.68 | 5.65 | 6.02 | 2.23 | 0.68 | 1.78 | 4.46 | 5.97 | 6.42 |
FCF Conversion (FCF/Net Income) | 1.21x | 1.38x | 1.05x | 1.65x | 0.72x | -0.09x | -0.41x | -0.68x | 1.27x | 1.16x |
Interest Paid | 0 | 0 | 0 | 0 | 9M | 17M | 73M | 83M | 0 | 0 |
Taxes Paid | 149M | 99M | 164M | 119M | 233M | 122M | 65M | 105M | 0 | 0 |
ILMN Key Ratios
Illumina, Inc. (ILMN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 26.85% | 23.61% | 23.45% | 14.1% | 9.87% | -50.8% | -18.81% | -30.13% | 33.36% | 32.84% |
Return on Invested Capital (ROIC) | 15.98% | 16.95% | 16% | 9.41% | -1.1% | -31.05% | -10.62% | -11.54% | 16.77% | 17.13% |
Gross Margin | 66.35% | 69.01% | 69.63% | 68.01% | 69.69% | 64.83% | 60.92% | 65.44% | 66.69% | 67.14% |
Net Margin | 26.38% | 24.78% | 28.28% | 20.25% | 16.84% | -96.07% | -25.78% | -27.97% | 19.59% | 19.43% |
Debt / Equity | 0.39x | 0.51x | 0.41x | 0.41x | 0.24x | 0.54x | 0.39x | 1.10x | 0.94x | 0.81x |
Interest Coverage | 29.19x | 16.68x | 22.50x | 18.47x | 15.49x | -165.77x | -13.51x | -10.79x | 8.55x | 12.09x |
FCF Conversion | 1.21x | 1.38x | 1.05x | 1.65x | 0.72x | -0.09x | -0.41x | -0.68x | 1.27x | 1.16x |
Revenue Growth | 14.74% | 21.11% | 6.3% | -8.58% | 39.73% | 1.28% | -1.75% | -2.93% | -0.78% | 1.25% |
Related:ILMN Dividend History·ILMN Revenue History·ILMN Price History·ILMN P/E History·ILMN Financial Ratios·ILMN Institutional Holders
ILMN SEC Filings & Documents
Illumina, Inc. (ILMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
ILMN Frequently Asked Questions
Illumina, Inc. (ILMN) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Illumina, Inc. (ILMN) reported $4.39B in revenue for fiscal year 2025. This represents a 926220% increase from $0.5M in 1999.
Illumina, Inc. (ILMN) saw revenue decline by 0.8% over the past year.
Yes, Illumina, Inc. (ILMN) is profitable, generating $853.0M in net income for fiscal year 2025 (19.6% net margin).
Dividend & Returns
Illumina, Inc. (ILMN) has a return on equity (ROE) of 33.4%. This is excellent, indicating efficient use of shareholder capital.
Illumina, Inc. (ILMN) generated $989.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.